For pharmacies and organisations

Professional procurement

Test solutions for pharmacies and organisations.

Choose between pharmacy and institutional STI products, professional drug and nicotine screening tests, or a scoped white-label project. Each route keeps product type, pricing access and intended use clear.

Separate B2B catalogue routesOrganisation-focused supportProduct-specific documentation
01
Pharmacy & institutional STISingle-test B2B products with protected business pricing.
02
Professional screeningBox-of-25 drug and nicotine screening formats.
03
White labelScoped branded test projects for suitable organisations.
Choose the right route

Different needs require different product flows.

Use the category that matches your organisation and purchasing purpose. Product-specific technical and regulatory information is confirmed against the exact released configuration.

Pharmacies · clinics · institutions

STI self-tests for B2B customers

Separate one-test chlamydia and gonorrhoea products for professional procurement. Business-specific prices are protected from guests and ordinary consumer accounts.

View institutional STI tests
Workplaces · care · education

Professional screening tests

Box-of-25 urine, saliva and cotinine screening formats for organisations operating documented testing programmes.

View professional-use tests
Brand and supply projects

White-label projects

Discuss a scoped branded-test project, including market, product configuration, quantity and documentation requirements.

Explore white-label projects
Business purchasing route

A clear path from catalogue to procurement.

Select the route

Choose institutional STI products, professional screening tests or a white-label enquiry.

Use a business account

Sign in or create a business account where business-specific catalogue information and pricing apply.

Confirm the product release

Review availability and exact product documentation before ordering. Current catalogue products remain non-purchasable while stock is zero.

Responsible implementation

The product is only one part of a professional programme.

Organisations using screening products should define purpose, authority, responsible personnel, privacy, consent, result handling, confirmation and follow-up. A screening result alone should not be treated as proof of impairment, misconduct or a diagnosis.

Before purchase

Define the setting

Clarify the organisation type, destination country, intended setting and expected quantity.

Before implementation

Prepare the procedure

Establish responsibilities, privacy safeguards, communication and an appropriate follow-up route.

Before use

Follow the exact IFU

Use the current instructions and product-specific interpretation rules supplied with the released configuration.

Need help choosing?

Tell us what your organisation needs.

Include organisation type, destination country, expected quantity and intended use so the enquiry can be routed correctly.